Physician profile
Daniel E Decamps
NPI 1669578373
$11,131.83
in general payments reported to CMS, 2019-2025
52 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $1,083 · 2021: $2,373 · 2022: $2,038 · 2023: $1,644 · 2024: $1,571 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,789.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,726.62 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals Lp | $1,625.65 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,234.72 | 2020-2025 | Ozempic, Rybelsus |
| Amgen INC. | $674.02 | 2019-2025 | Otezla, Repatha, Otezla |
| Amarin Pharma, INC. | $538.79 | 2019-2022 | |
| Astellas Pharma US INC | $458.90 | 2019-2023 | Myrbetriq |
| Forte Bio-Pharma LLC | $411.39 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Janssen Pharmaceuticals, INC | $383.34 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $336.90 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $321.19 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Exact Sciences Corporation | $250.71 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $241.03 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.04 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $219.15 | 2019-2025 | |
| Lilly USA, LLC | $215.66 | 2020-2025 | Mounjaro, Zepbound |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Decamps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.